Latest Virginia G. Piper Cancer Center Stories
A new investigational drug designed to penetrate and attack pancreatic cancer cells has been administered to a patient for the first time ever at the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
Broadcast, cable television networks plan star-studded fundraising telethon on Sept. 10 SCOTTSDALE, Ariz., Sept. 8 /PRNewswire-USNewswire/ -- The Virginia G.
Sept. 11 community event includes daVinci surgical robot, prostate health talks & healthy cooking demos SCOTTSDALE, Ariz., Sept. 2 /PRNewswire-USNewswire/ -- Recognizing that early detection can save lives, the Virginia G.
Virginia G. Piper Cancer Center researcher honored for cancer research, new treatments SCOTTSDALE, Ariz., June 2 /PRNewswire-USNewswire/ -- Oncologist Daniel Von Hoff, MD, chief scientific officer at the Virginia G.
Accreditation with Commendation granted by Commission on Cancer SCOTTSDALE, Ariz., April 14 /PRNewswire-USNewswire/ -- The Commission on Cancer of the American College of Surgeons has granted Accreditation with Commendation to the cancer program at Scottsdale Healthcare. Included in the accreditation are the Virginia G.
TGen, Virginia G. Piper Cancer Center and Side-Out Foundation team up for 'next generation' treatment
PCI-32765 is a new drug being assessed in a Phase I clinical trial at the Virginia G Piper Cancer Center in collaboration with the Clinical Division of the Translational Genomics Research Institute.
Black tie event proceeds benefit Virginia G. Piper Cancer Center at Scottsdale Healthcare SCOTTSDALE, Ariz., Dec. 9 /PRNewswire-USNewswire/ -- Scottsdale Healthcare Foundation announced today that Daniel Von Hoff, MD will be Honoree at its 34th annual Honor Ball. Dr.
Hedgehog trial results suggest antitumor activity in basal cell skin cancer SCOTTSDALE, Ariz., Sept.
- A serpent whose bite was fabled to produce intense thirst.